MRP1 transports a wide range of therapeutic agents as well as various physiological substrates and may contribute to drug resistance development in several cancers, including lung, breast, and prostate cancers, as well as childhood neuroblastoma [200]. This evidence concerns the gene ABCC1 and prostate cancer.